BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18495909)

  • 1. How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?
    Fewtrell MS; Kennedy K; Singhal A; Martin RM; Ness A; Hadders-Algra M; Koletzko B; Lucas A
    Arch Dis Child; 2008 Jun; 93(6):458-61. PubMed ID: 18495909
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving neurologic and quality-of-life outcomes in children with congenital heart disease: past, present, and future.
    Wernovsky G
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):240-2, 242.e1-2. PubMed ID: 18242241
    [No Abstract]   [Full Text] [Related]  

  • 3. Reporting attrition in randomised controlled trials.
    Dumville JC; Torgerson DJ; Hewitt CE
    BMJ; 2006 Apr; 332(7547):969-71. PubMed ID: 16627519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of missing data due to selective dropouts in cohort studies and clinical trials.
    Touloumi G; Pocock SJ; Babiker AG; Darbyshire JH
    Epidemiology; 2002 May; 13(3):347-55. PubMed ID: 11964938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical myology at the crossroads; the gospel truth.
    Dubowitz V
    Neuromuscul Disord; 2010 Feb; 20(2):95-6. PubMed ID: 20142012
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review.
    Akl EA; Briel M; You JJ; Sun X; Johnston BC; Busse JW; Mulla S; Lamontagne F; Bassler D; Vera C; Alshurafa M; Katsios CM; Zhou Q; Cukierman-Yaffe T; Gangji A; Mills EJ; Walter SD; Cook DJ; Schünemann HJ; Altman DG; Guyatt GH
    BMJ; 2012 May; 344():e2809. PubMed ID: 22611167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A think-tank on nutrition in the primary prevention of low birthweight, cerebral palsy and related handicaps.
    Crawford MA
    Nutr Health; 1992; 8(1):45-55. PubMed ID: 1376464
    [No Abstract]   [Full Text] [Related]  

  • 8. Bayesian Analysis: A Practical Approach to Interpret Clinical Trials and Create Clinical Practice Guidelines.
    Bittl JA; He Y
    Circ Cardiovasc Qual Outcomes; 2017 Aug; 10(8):. PubMed ID: 28798016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of macronutrient supplements for children born preterm or small for gestational age on developmental and metabolic outcomes: A systematic review and meta-analysis.
    Lin L; Amissah E; Gamble GD; Crowther CA; Harding JE
    PLoS Med; 2019 Oct; 16(10):e1002952. PubMed ID: 31665140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the quality of reporting in randomised controlled trials.
    Walker A; Nixon J
    J Wound Care; 2004 Mar; 13(3):103-6. PubMed ID: 15045804
    [No Abstract]   [Full Text] [Related]  

  • 11. [STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE].
    Ernest P; Jandrain B; Scheen AJ
    Rev Med Liege; 2015; 70(5-6):232-6. PubMed ID: 26285444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of preterm children: important to document dropouts.
    Wolke D; Söhne B; Ohrt B; Riegel K
    Lancet; 1995 Feb; 345(8947):447. PubMed ID: 7531802
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishing a translational science for autistic spectrum disorders for children and their families: optimizing function, participation, and well-being.
    Msall ME
    J Pediatr; 2009 Mar; 154(3):319-21. PubMed ID: 19874754
    [No Abstract]   [Full Text] [Related]  

  • 14. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 15. Does iron-deficiency anemia affect child development?
    Grantham-McGregor S
    Pediatrics; 2003 Oct; 112(4):978. PubMed ID: 14523198
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of proper conduct of clinical trials.
    Cortegiani A; Absalom AR
    Br J Anaesth; 2021 Feb; 126(2):354-356. PubMed ID: 33121749
    [No Abstract]   [Full Text] [Related]  

  • 17. Docosahexaenoic acid (DHA). Monograph.
    Altern Med Rev; 2009 Dec; 14(4):391-9. PubMed ID: 20030466
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quality analyses of the development of preterm infants: results of the Lower-Saxonian preterm infant follow-up project and a comparison group of term infants].
    Damm G; Macha T; Petermann F; Voss W; Sens B
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(1):6-17. PubMed ID: 25839361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can we evaluate developmental care practices prior to their implementation in a neonatal intensive care unit?
    Pierrat V; Goubet N; Peifer K; Sizun J
    Early Hum Dev; 2007 Jul; 83(7):415-8. PubMed ID: 17433578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the promise of randomized control trials ("evidence-based medicine") overstated?
    Caplan LR
    Curr Neurol Neurosci Rep; 2002 Jan; 2(1):1-8. PubMed ID: 11898575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.